Evidence map›Paper›PMID 26070998›Full record

ArticleEuropean journal of pediatrics2015

Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein.

Tiina Ojala, Irmeli Nupponen, Carola Saloranta, Taisto Sarkola, Priya Sekar, Anniina Breilin, Tiina Tyni

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Mitochondrial trifunctional protein deficiency due toMolecular genetics and metabolism reports · 2015
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tiina OjalaDepartment on Pediatrics, Children's Hospital, University Hospital of Helsinki, Stenbackinkatu 11, PL 281, 00029 HUS, Helsinki, Finland. tiina.h.ojala@hus.fi.
Irmeli NupponenDepartment on Pediatrics, Children's Hospital, University Hospital of Helsinki, Stenbackinkatu 11, PL 281, 00029 HUS, Helsinki, Finland. irmeli.nupponen@hus.fi.
Carola SalorantaDepartment of Clinical Genetics, Finland and Fetomaternal Center, Helsinki University Hospital, Helsinki, Finland. carola.saloranta@hus.fi.
Taisto SarkolaDepartment on Pediatrics, Children's Hospital, University Hospital of Helsinki, Stenbackinkatu 11, PL 281, 00029 HUS, Helsinki, Finland. taisto.sarkola@hus.fi.
Priya SekarDepartment of Pediatric Cardiology, The John Hopkins Hospital, Baltimore, MD, USA. psekar1@jhmi.edu.
Anniina BreilinDepartment on Pediatrics, Children's Hospital, University Hospital of Helsinki, Stenbackinkatu 11, PL 281, 00029 HUS, Helsinki, Finland. anniina.breilin@fimnet.fi.
Tiina TyniDepartment on Pediatrics, Children's Hospital, University Hospital of Helsinki, Stenbackinkatu 11, PL 281, 00029 HUS, Helsinki, Finland. tiina.tyni@helsinki.fi.
Helsinki University Hospital · FIJohns Hopkins Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a fetal case with fatal outcome having a novel mutation in the HADHB gene, coding the beta-subunit of the mitochondrial trifunctional protein. Parents had a previous pregnancy loss due to fetal heart failure and hydrops. The next pregnancy led to left ventricular noncompaction and increasing pleural effusions after 29 gestational weeks. The fetus was small for gestational age, and long bones were abnormally short. The baby was born severely asphyxiated at 32 gestational weeks by cesarean section. Intensive care was withdrawn due to failure to thrive and suspicion of a severe mitochondrial disorder. Postmortem brain MRI suggested microcephaly with a simplified gyral pattern. The lateral cerebral ventricles were normal. Chromosome analysis was normal (46, XX). Fibroblasts cultured from a skin biopsy of the baby revealed the large homozygous deletion c.1109+243_1438-703del in the HADHB gene, and heterozygous mutations were detected in both parents. The deletion has not been reported earlier.

conclusionIt is important to differentiate systemic metabolic diseases from disorders that affect only the cardiac muscle. Trifunctional protein deficiency is a relatively rare disorder of the fatty acid β-oxidation cycle. The mutation in the HADHB gene causes a systemic disease with early-onset cardiomyopathy. Understanding the molecular genetic defect of the patient allows appropriate genetic counseling of the family. WHAT IS KNOWN: • Mitochondrial disorders as a group are an important etiology for fetal cardiomyopathies including human trifunctional protein (TFP) disorders and several other mitochondrial diseases. WHAT IS NEW: • We report a fetal case with fatal outcome having a novel mitochondrial trifunctional protein mutation (c.1109+243_1438-703del in the HADHB gene).

Indexed as

AdultCardiomyopathiesEchocardiographyFatal OutcomeFemaleFetal DiseasesFetusHeart VentriclesHumansLipid Metabolism, Inborn ErrorsMitochondrial MyopathiesMitochondrial Trifunctional ProteinMitochondrial Trifunctional Protein, beta SubunitMutationNervous System DiseasesPregnancyHADHB protein, humanMitochondrial Trifunctional ProteinMitochondrial Trifunctional Protein, beta SubunitEchocardiographyFetal cardiomyopathyNoncompaction cardiomyopathyTrifunctional protein

Identifiers

PMID26070998
OpenAlexW571300672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.